NextPlat Q2 EPS Boosted by Litchfield Hills Research

NextPlat Corp. (NASDAQ:NXPL) – Equities researchers at Litchfield Hills Research increased their Q2 2027 EPS estimates for shares of NextPlat in a research report issued on Thursday, July 16th. Litchfield Hills Research analyst T. O’neill now expects that the company will post earnings of $0.15 per share for the quarter, up from their previous forecast of $0.14. Litchfield Hills Research currently has a “Buy” rating and a $11.00 target price on the stock. The consensus estimate for NextPlat’s current full-year earnings is ($0.55) per share. Litchfield Hills Research also issued estimates for NextPlat’s Q4 2027 earnings at $0.18 EPS and FY2027 earnings at $0.58 EPS.

NextPlat (NASDAQ:NXPL) last issued its quarterly earnings data on Thursday, May 14th. The company reported ($0.42) EPS for the quarter. The business had revenue of $9.86 million for the quarter. NextPlat had a negative return on equity of 58.05% and a negative net margin of 23.14%.

Other equities analysts have also issued reports about the company. Zacks Research upgraded NextPlat to a “hold” rating in a research report on Thursday, June 25th. Weiss Ratings upgraded shares of NextPlat from a “sell (e+)” rating to a “sell (d-)” rating in a report on Monday, May 11th. One analyst has rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, NextPlat has an average rating of “Hold” and an average price target of $11.00.

NextPlat Stock Down 8.3%

Shares of NextPlat stock opened at $6.06 on Friday. The company has a market capitalization of $16.42 million, a P/E ratio of -1.40 and a beta of 1.87. The company has a debt-to-equity ratio of 0.05, a current ratio of 2.56 and a quick ratio of 2.12. The business has a 50-day moving average of $6.53 and a two-hundred day moving average of $5.98. NextPlat has a 1 year low of $3.38 and a 1 year high of $11.10.

Institutional Trading of NextPlat

A hedge fund recently bought a new position in NextPlat stock. Citadel Advisors LLC bought a new position in shares of NextPlat Corp. (NASDAQ:NXPL) in the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 48,176 shares of the company’s stock, valued at approximately $40,000. Citadel Advisors LLC owned about 0.19% of NextPlat at the end of the most recent quarter. 1.30% of the stock is currently owned by institutional investors and hedge funds.

NextPlat Company Profile

NextPlat Corp operates as a healthcare and e-commerce company in Europe, North America, South America, the Asia and Pacific, and Africa. The company operates full-service retail specialty services pharmacies that provides prescription pharmaceuticals prescription pharmaceuticals, third-party administration, risk and data management services, compounded medications, tele-pharmacy services, anti-retroviral medications, medication therapy management, contracted pharmacy services, and health practice risk management to healthcare organizations and providers, as well as supplies prescription medications to long-term care facilities.